Literature DB >> 9212117

Intracoronary levosimendan enhances contractile function of stunned myocardium.

I N Jamali1, J R Kersten, P S Pagel, D A Hettrick, D C Warltier.   

Abstract

A decrease in myofilament sensitivity to Ca2+ has been proposed as a mechanism for reversible contractile dysfunction after ischemia and reperfusion. The direct actions of intracoronary myofilament Ca2+ sensitizers on stunned myocardium have not been examined. Barbiturate-anesthetized dogs (n = 9) were instrumented for measurement of left ventricular (LV) and aortic blood pressure, cardiac output, left anterior descending coronary artery (LAD) blood flow velocity, and subendocardial segment length (percent segment shortening [%SS]). Dogs were subjected to five 5-min LAD occlusions interspersed by 5-min reperfusions. Three hours after the final reperfusion, levosimendan (1.5, 3, 6, and 12 microg/min) was administered via an intracoronary catheter. Hemodynamic effects and regional myocardial function were determined under control conditions, during each LAD occlusion and reperfusion, 3 h after final reperfusion, and after 10 min equilibration at each dose of levosimendan. Three hours after the final reperfusion, %SS and the ratio of effective to total regional work were significantly (P < 0.05) decreased, and postsystolic shortening area was increased, consistent with myocardial stunning. In stunned myocardium, intracoronary levosimendan caused dose-dependent increases in %SS (2 +/- 1 at 3 h after reperfusion to 13% +/- 2% during 12 microg/min), abolished postsystolic shortening area, and restored the ratio of effective to total regional work while producing minimum systemic hemodynamic effects.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9212117     DOI: 10.1097/00000539-199707000-00005

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  16 in total

Review 1.  Levosimendan.

Authors:  D P Figgitt; P S Gillies; K L Goa
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 2.  Levosimendan: A promising agent for the treatment of hospitalized patients with decompensated heart failure.

Authors:  L Lehtonen
Journal:  Curr Cardiol Rep       Date:  2000-05       Impact factor: 2.931

Review 3.  [Role of Levosimendan in intensive care treatment of myocardial insufficiency].

Authors:  S Rehberg; C Ertmer; H Van Aken; M Lange; K Bröking; A Morelli; M Westphal
Journal:  Anaesthesist       Date:  2007-01       Impact factor: 1.041

Review 4.  Levosimendan: a calcium-sensitizing agent for the treatment of patients with decompensated heart failure.

Authors:  Lasse Lehtonen
Journal:  Curr Heart Fail Rep       Date:  2004-09

5.  Analysis of the influences of short-term levosimendan exposure on oxidant/antioxidant status and trace-element levels in the physiological status of the thoracic aorta of rats.

Authors:  Cemalettin Aydin; Yasin Ay; Halil Basel; Servet Kavak; Bekir Inan; Hava Bektaş; Hasan Ali Gümrükçüoğlu; Hasan Ekim; Halit Demir
Journal:  J Membr Biol       Date:  2012-07-29       Impact factor: 1.843

Review 6.  Levosimendan: a review of its use in the management of acute decompensated heart failure.

Authors:  Carmen A Innes; Antona J Wagstaff
Journal:  Drugs       Date:  2003       Impact factor: 9.546

Review 7.  [Levosimendan. Clinical indications of a new vasoactive substance].

Authors:  J-P Braun; U Döpfmer; M Kastrup; I Roots; A Borges; M Schneider; P Dohmen; W Kox; C Spies
Journal:  Anaesthesist       Date:  2004-02       Impact factor: 1.041

Review 8.  [Cardiogenic shock: pathophysiology, clinics, therapeutical options and perspectives].

Authors:  R Prondzinsky; K Werdan; M Buerke
Journal:  Internist (Berl)       Date:  2004-03       Impact factor: 0.743

9.  Newer treatments for decompensated heart failure: focus on levosimendan.

Authors:  Ferenc Follath
Journal:  Drug Des Devel Ther       Date:  2009-09-21       Impact factor: 4.162

10.  The effects of levosimendan exposure on oxidant/antioxidant status and trace element levels in the pulmonary artery of rats.

Authors:  Yasin Ay; Cemalettin Aydın; Halil Basel; Hava Bektaş; Gülay Bülüt; Bekir Inan; Nuray Kahraman Ay; Ismail Demir
Journal:  J Membr Biol       Date:  2013-05-15       Impact factor: 1.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.